Monitoring Ambient Temperatures Experienced During Delivery of Human Papillomavirus Vaccine in Uganda
This report discusses a five-year human papillomavirus (HPV) vaccine demonstration project in Uganda that aims to demonstrate how existing health systems can be adapted to successfully provide HPV vaccine to young adolescent girls. HPV vaccine is a strong candidate for storage and transport in a controlled temperature chain at temperatures higher than the standard 2º to 8ºC cold chain storage.
Author: PATH, World Health Organization
» Download file (English)
710 KB PDF (Located at www.path.org)
Diseases/vaccines: Human papillomavirus (HPV)